Marco Michelutti
Overview
Explore the profile of Marco Michelutti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Michelutti M, Urso D, Tafuri B, Gnoni V, Giugno A, Zecca C, et al.
J Alzheimers Dis
. 2025 Feb;
:13872877251316794.
PMID: 39956966
Background: The frequent presentation of Alzheimer's disease (AD) with neuropsychiatric symptoms (NPS) in the context of normal or minimally-impaired cognitive function led to the concept of Mild Behavioral Impairment (MBI)....
2.
Furlanis G, Buoite Stella A, Torresin G, Michelutti M, Ajcevic M, Manganotti P
Clin Neurol Neurosurg
. 2024 Sep;
246:108522.
PMID: 39276663
Introduction: Long-COVID is a multisystem disease characterized by a varied presentation of symptoms. According to most recent research, the most common symptom of long-COVID is fatigue, which up to this...
3.
Ilardi C, Menichelli A, Michelutti M, Cattaruzza T, Federico G, Salvatore M, et al.
J Alzheimers Dis
. 2024 Aug;
101(1):293-308.
PMID: 39150828
Background: In the era of disease-modifying therapies, empowering the clinical neuropsychologist's toolkit for timely identification of mild cognitive impairment (MCI) is crucial. Objective: Here we examine the clinimetric properties of...
4.
Michelutti M, Urso D, Gnoni V, Giugno A, Zecca C, Vilella D, et al.
J Alzheimers Dis
. 2024 Feb;
98(2):425-432.
PMID: 38393901
Background: Behavioral variant frontotemporal dementia (bvFTD) typically involves subtle changes in personality that can delay a timely diagnosis. Objective: Here, we report the case of a patient diagnosed of GRN-positive...
5.
Manganotti P, Michelutti M, Furlanis G, Deodato M, Buoite Stella A
Clin Neurophysiol
. 2023 May;
151:83-91.
PMID: 37210757
Objective: Attention, working memory and executive processing have been reported to be consistently impaired in Neuro-Long coronavirus disease (COVID). On the hypothesis of abnormal cortical excitability, we investigated the functional...
6.
Ajcevic M, Iscra K, Furlanis G, Michelutti M, Miladinovic A, Buoite Stella A, et al.
Sci Rep
. 2023 Apr;
13(1):5808.
PMID: 37037833
Cognitive impairment is one of the most prevalent symptoms of post Severe Acute Respiratory Syndrome COronaVirus 2 (SARS-CoV-2) state, which is known as Long COVID. Advanced neuroimaging techniques may contribute...
7.
Ilardi C, Menichelli A, Michelutti M, Cattaruzza T, Manganotti P
Neurol Sci
. 2022 Sep;
44(1):159-170.
PMID: 36169756
Objective: In this phase II psychometric study on the Montreal cognitive assessment (MoCA), we tested the clinicometric properties of Italian norms for patients with mild cognitive impairment (PwMCI) and early...
8.
Michelutti M, Furlanis G, Buoite Stella A, Bellavita G, Frezza N, Torresin G, et al.
J Neurol Sci
. 2022 Aug;
441:120355.
PMID: 35994869
"Long-COVID" is a clinical entity that consists of persisting post-infectious symptoms that last for more than three months after the onset of the first acute COVID-19 symptoms. Among these, a...
9.
Van Overwalle F, Manto M, Cattaneo Z, Clausi S, Ferrari C, Gabrieli J, et al.
Cerebellum
. 2020 Jul;
19(6):833-868.
PMID: 32632709
The traditional view on the cerebellum is that it controls motor behavior. Although recent work has revealed that the cerebellum supports also nonmotor functions such as cognition and affect, only...